TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 177 filers reported holding TG THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,819,828 | -79.4% | 337,300 | -38.8% | 0.04% | -82.2% |
Q2 2023 | $13,689,324 | +255.9% | 551,100 | +115.5% | 0.24% | +227.0% |
Q1 2023 | $3,846,164 | -76.7% | 255,729 | -81.7% | 0.07% | -71.2% |
Q4 2022 | $16,514,680 | +327.7% | 1,396,000 | +113.9% | 0.26% | +375.9% |
Q3 2022 | $3,861,000 | +25.7% | 652,500 | -9.7% | 0.05% | +25.6% |
Q2 2022 | $3,071,000 | +76.8% | 722,500 | +296.1% | 0.04% | +104.8% |
Q1 2022 | $1,737,000 | -92.9% | 182,400 | -85.7% | 0.02% | -92.3% |
Q4 2021 | $24,317,000 | +395.3% | 1,279,800 | +767.7% | 0.27% | +385.7% |
Q3 2021 | $4,910,000 | -2.8% | 147,500 | +13.2% | 0.06% | -16.4% |
Q2 2021 | $5,051,000 | +2836.6% | 130,250 | +1380.1% | 0.07% | +1016.7% |
Q2 2020 | $172,000 | -95.8% | 8,800 | -97.9% | 0.01% | -97.4% |
Q1 2020 | $4,092,000 | +22.1% | 415,900 | +37.9% | 0.23% | +104.4% |
Q4 2019 | $3,350,000 | +159.9% | 301,700 | +102.5% | 0.11% | +73.8% |
Q2 2019 | $1,289,000 | -40.8% | 149,000 | -61.7% | 0.06% | -45.8% |
Q3 2018 | $2,179,000 | – | 389,100 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 8,198,337 | $33,613,000 | 1.96% |
GREAT POINT PARTNERS LLC | 3,000,000 | $12,300,000 | 1.56% |
BRIDGER MANAGEMENT, LLC | 3,791,531 | $15,545,000 | 1.30% |
Avoro Capital Advisors LLC | 4,750,000 | $19,475,000 | 1.16% |
Opaleye Management Inc. | 550,000 | $2,255,000 | 0.84% |
CREDIT AGRICOLE S A | 1,307,428 | $5,360,000 | 0.30% |
Eversept Partners, LP | 65,000 | $266,500 | 0.14% |
HIGHLAND CAPITAL MANAGEMENT LP | 453,360 | $1,859,000 | 0.14% |
683 Capital Management, LLC | 500,000 | $2,050,000 | 0.12% |
Artal Group S.A. | 400,000 | $1,640,000 | 0.06% |